Published in AIDS Weekly, October 15th, 2001
These new patents expand their intellectual property protection to the C strain (clade) of the HIV virus, which is the most prevalent strain in the world and is also the dominant strain in the developing world.
The first patent describes an improved version of the already patented HGP-30 peptide that contains within its sequence several epitopes (small pieces of around 8-10 amino acids found within foreign proteins) against which the immune system reacts. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.